Document:

Core Distribution Agreement

 EXHIBIT 10.2 
 Confidential Materials omitted and filed separately with the 
 Securities and Exchange Commission. Asterisks
denote omissions. 
  
 McKesson Corporation

 Core Distribution Agreement 
  

This Core Distribution Agreement (“Agreement”) is entered into between McKesson Corporation (“McKesson”), a pharmaceutical distributor, and
CollaGenex Pharmaceuticals (“Manufacturer”), a pharmaceutical manufacturer. 
  
 McKesson performs certain Core Services (as hereinafter defined) in connection with the distribution of pharmaceutical products manufactured by Manufacturers. The parties now wish to define more precisely the amount
and manner of payment of the consideration to be received by McKesson for its performance of the Core Services. 
  
 Now, therefore, McKesson and Manufacturer agree as follows: 
  

	 	I.	Obligations of McKesson 

  

	 	a.	McKesson agrees to provide the following core distribution services to the extent customarily performed by a full-range pharmaceutical distributor consistent with then current
industry practices (“Core Services”): Pick, pack, and ship Manufacturer’s product to McKesson’s customers upon their orders therefore; transmit 852 data including inventory levels on hand and on order in addition to aggregate
sales out; transmit 867 data, not in violation of McKesson’s contracts with customers, on an quarterly basis; perform back-end administrative services to support the distribution of Manufacturer’s product and the maintenance of efficient
inventory levels for servicing customers. 

  
 If
McKesson new product launch criteria are met McKesson will support Manufacturer’s new product launch by stocking each distribution center with a reasonable quantity (not to exceed [**] days). 
  

	 	b.	Services that are not Core Services (“Value Added Services”), are not included in this Agreement and shall be priced individually and separate from this Agreement. Value
Added Services include the following: single point distribution through McKesson’s Regional Distribution Center (“RDC”) or Strategic Redistribution Center, RDC product backhaul, guaranteed service levels, product recalls, product
returns management, promotional marketing services, rapid distribution for new product launches, and all other services not defined as Core Services in Section I.a. above. 

	 	c.	McKesson will use best efforts to maintain Aggregate Inventory levels in the range of [**] weeks of all products. 

  

	 	d.	McKesson agrees not to engage in forward buying of CollaGenex products. McKesson further agrees to buy between [**]% and [**]% of Average Monthly Purchases based on the previous
rolling six months of purchases. A deviation from these collars due to market dynamics (i.e. customer base change, seasonality, competitive introduction, etc) will not be seen as a violation. 

  

	 	e.	McKesson agrees not to sell Manufacturer’s products to other wholesalers and secondary buying groups. 

  

	 	II.	Obligations of Manufacturer 

  

	 	a.	Manufacturer agrees to replenish McKesson’s inventory orders in a timely and efficient manner. Manufacturer will utilize purchase order numbers provided by McKesson when
placing orders on behalf of McKesson. 

  

	 	b.	Manufacturer will use commercially reasonable efforts to ensure that McKesson’s inventory replenishment is operational, except for any scheduled down time needed to maintain
effective operations and/or when interruptions are necessary or caused by conditions outside of Manufacturer’s control. 

  

	 	c.	In consideration of the Core Services to be provided pursuant to this Agreement, Manufacturer will pay a fee to McKesson determined in accordance with Attachment A.

  

	 	III.	Additional Terms and Conditions 

  

	 	a.	Payment calculations are all based on gross branded pharmaceutical sales by Manufacturer to McKesson. 

  

	 	b.	All fees hereunder will be due and payable with respect to any sales by Manufacturer as described in Attachment A. 

  

	 	c.	Any fees past due will be deducted by McKesson. 

	 	IV.	Adjustment of Terms 

  
 In the event that Manufacturer [**] with regard to distribution of products [**] (and taking into account the nature and amount of data and services
provided), [**], effective from and after the date that Manufacturer [**]. 
  

	 	V.	Confidentiality and Disclosure 

  
 This Agreement and all information which is provided by each party to the other party pursuant to this Agreement are confidential. Each party agrees to
maintain all such information confidential and except as may be required by law or order of any court or governmental agency, not to disclose to any third party any such information unless such party shall obtain a written release from the other
party. Each party further agrees to limit access to such information to only those of its officers and employees who reasonably need to know such information. 
  

	 	VI.	Effective Date 

  

	 	a.	This Agreement shall become effective as of April 1, 2005 and shall remain in effect until March 31, 2008 or when terminated in accordance with Section b., below.

  

	 	b.	Either party may terminate this Agreement with or without cause at any time on thirty days prior written notice to the other party. 

  

	 	VII.	General 

  

	 	a.	This Agreement shall supersede any existing agreement in effect between McKesson and Manufacturer, including the current Inventory Management Agreement executed March 1, 2003
between the parties. 

  

	 	b.	This Agreement shall not supersede the McKesson Buying Terms Form executed October 16, 1998. 

  

	 	c.	This Agreement will be governed by and construed in accordance with the laws of Delaware, without regard to or application of conflict of law, rules or principles.

  

	 	d.	In no event shall McKesson be liable to Manufacturer for any special, consequential, incidental or indirect damages, however caused, on any theory of liability and whether or not
McKesson has been advised of the possibility of such damages. 

	 	e.	The parties to this Agreement are independent contractors. Accordingly, this Agreement does not constitute a partnership or other joint venture between the parties and neither party
shall be deemed to be an agent or representative of the other. 

  

	 	f.	The failure of either party to enforce at any time or for any period of time any one or more of the provisions hereof shall not be construed to be a waiver of such provisions or of
the right of such party thereafter to enforce each such provision. 

  

	 	g.	Except for the obligation to pay money, neither party will be liable to the other party for any failure or delay in performance caused by reasons beyond such party’s reasonable
control, including but not limited to acts of God, war, riot, acts of terrorism, fire, shortage of materials or transportation, strikes or acts of civil or military authorities, provided such party gives prompt written notice thereof to the other
party. 

  

	 	h.	In the event Manufacturer requires services (i.e. distribution, pharmacy, marketing or logistics) that McKesson Specialty can provide, McKesson Specialty will be given the
opportunity to bid on providing these services to Manufacturer at the time they may be put out for bid, along with any other competitor(s) that Manufacturer may so choose. 

  
 For CollaGenex Pharma, a pharmaceutical manufacturer: 
  

			
	By:	 	 /s/ David Pfeiffer

	Name:	 	David Pfeiffer
	 	 	(Print or Type)
	Title:	 	Sr. V.P., Sales & Marketing
	
	Date: 4/19/05
	
	For McKesson:
		
	By:	 	 /s/ Mark Miller

	Name:	 	Mark Miller
	 	 	(Print or Type)
	Title:	 	V.P. Investment Purchasing
	
	Date: 4/28/05

 Attachment A – 
  
 McKesson Core Distribution Agreement Fee 
 Services Fee Schedule 
  
 Total Annual Fee for Services Provided – [**]% of gross purchases 
  
 A fee of [**]% will be calculated and invoiced by McKesson on a Calendar quarter basis. Back-up documentation of all fees and calculations will be provided with the invoice. [**] day payment terms will apply to fees
payable from the previous quarter. 
  
 In a letter, on Manufacturer company letter
head, Manufacturer will change the payment terms for invoices during agreement effective dates to [**]%, net [**] days. Manufacturer will amend existing wholesaler payment terms on all invoices during the term of this agreement to [**] if payment is
received within [**] days of invoice date.Letter of Agreement dated April 26, 2005

 Exhibit 10.1 
  

			
	

	 	3801 West Hillsboro Boulevard * Deerfield Beach * Florida * 33442 * 954.360.9022

  
 VIA HAND DELIVERY

  
 April 26, 2005 
  
 Mr. Robert Hamilton 
  
 RE: Terms of Employment Between eDiets.com, Inc. and Robert Hamilton 
  
 Dear Mr. Hamilton: 
  
 This will serve to confirm the terms of your employment with eDiets.com, Inc. and all affiliates of eDiets.com, Inc. (“EDI,” “We” or
“Us). 
  

	 	1.	Term. Subject to the following terms and conditions, this Agreement is effective as of April 26, 2005 and will continue for eighteen (18) months thereafter unless terminated
at the option of the parties and pursuant to the terms expressed below. This Agreement may be renewed upon agreement by the parties. 

  

	 	2.	Duties. You are employed as Chief Financial Officer and, as such, shall perform all duties commonly incident to this office, including such additional duties as the Board of
Directors (the “Board”) shall prescribe from time to time. 

  

	 	3.	Compensation and Benefits. Your “Base Salary” will be no less than $189,000, and shall be reviewed at least annually in January of each year during the term of your
employment. You will be entitled to not less than 160 hours of “PTO” per year, and your other benefits will be provided at levels not less than those provided in our company benefit program. 

  

	 	4.	Performance of Duties. During the term of your employment, you shall devote your full working time, ability and attention to the business of EDI. 

  

	 	5.	Stock Options. You have received, or will receive as of the above date, a non-incentive stock option (the “Option”) under our Stock Option Plan(s) in effect as of
the above date (the “Plan”). The Option, and any other options granted by us to you, shall have such terms as are required by the Plan and which may be implemented by the Board but, notwithstanding, shall fully vest upon a termination of
your employment by us without “cause” or by you for “good reason,” or upon a “Change of Control,” death or disability. In the event of a conflict between the terms this Agreement and the terms of the Plan or any stock
option agreement pursuant thereto, the terms of this Agreement shall control. 

  

	 	6.	“Change of Control.” A “Change of Control” shall be deemed to have occurred if (1) there shall be consummated (a) any consolidation or merger of EDI in
which EDI is not the continuing or surviving corporation or pursuant to which shares of EDI’s Common Stock would be converted into cash, securities or other property, other than a merger of EDI in which the holders of EDI’s Common Stock
immediately prior to the merger continue to control the surviving corporation immediately after the merger and other than a merger of EDI with an affiliate of EDI, or (b) any sale, lease, exchange or other transfer (in one transaction or a series of
related transactions) of all, or substantially all, of the assets of EDI, or (2) the shareholders of EDI approve any plan or proposal for the liquidation or dissolution of EDI or (3) any person (as such term is used in Sections 13(d) and 14(d)(2) of
the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), shall become the beneficial owner (within the meaning of Rule 13d-3 under the Exchange Act) of 80% or more of the combined voting power of EDI’s outstanding voting
securities. The employment terms expressed in this letter shall survive a change of control. 

  

	 	7.	Termination by EDI for Cause. We may terminate your employment “for cause” at any time. As used herein, for “cause” shall mean any one of the following:

  

	 	a.	The willful breach or habitual neglect by you of your job duties and responsibilities; or 

	 	b.	Conviction of any felony, excluding minor traffic offenses; or 

  

	 	c.	Commission of an act of fraud, embezzlement or material misappropriation or dishonesty against EDI or any of EDI’s affiliates; or 

  

	 	d.	Commission of a serious violation of any of EDI’s personnel policies, including but not limited to violations of EDI’s policies against any form of harassment.

  
 In the event we terminate your employment for
cause, your Base Salary, incentive compensation, benefits, and the unexercised portion of the Option (and any other stock options) shall automatically terminate as of the effective date of such termination. 
  

	 	8.	Termination by EDI Without Cause or by You for Good Reason or Upon a Change of Control. We may terminate your employment without cause at any time upon 30 days’ prior
written notice to you. You shall have the right to terminate this Agreement at any time for “good reason” or upon a change of control. “Good reason” means the occurrence of any of the following without your prior written consent:
(i) the assignment to you of duties and responsibilities that are unethical, illegal or inconsistent, in a material and adverse respect, with the scope of the duties and responsibilities usually vested in similarly situated executives; (ii) a
material reduction in the benefits payable to you; or (iii) a requirement that you perform your primary duties at a location outside of Broward and Palm Beach Counties in the state of Florida, USA. We shall pay to you on the date of termination
without cause or for good reason a severance allowance of an amount equal to Six (6) months’ Base Salary, plus one (1) month for each year of service to EDI at your then-effective rate, plus all accrued but unpaid allowances, expense
reimbursements, bonuses, and commissions. We shall pay to you on the date of termination for a change in control a severance allowance of an amount equal to twelve (12) months’ Base Salary at your then effective rate. Upon termination by EDI
without cause or by you for good reason or upon change of control, we will reimburse you for expenses relating to the extension of health benefits under COBRA for a period of six (6) months after termination. Additionally, any unvested shares under
the Option (and any other Stock Options granted under the Plan) shall vest immediately and shall be exercisable by you for sixty (60) days following the date of termination upon change of control or for twelve (12) months following the date of
termination by EDI without cause or by you for good reason. 

  

	 	9.	Termination by You Without Good Reason. You may terminate your employment without good reason upon 30 days’ prior written notice to the Company. In such a case, you may
be required to perform your business duties and shall be paid your regular salary up to the date of the termination. At our option, we may require you to depart upon receiving the 30 days’ notice. In this event, we shall pay you an amount equal
to 30 calendar days of your Base Salary at the then-effective rate and all accrued but unpaid allowances and expense reimbursements, and you shall not be entitled to receive any other compensation or severance allowance. Any unexercised and unvested
shares granted pursuant to the Option (and any other stock options granted under the Plan) shall be exercisable in accordance with the terms thereof. 

  

	 	10.	Death or Disability. In the event of your death, your employment and your future Base Salary, incentive compensation and benefits shall automatically terminate, except for
(a) any vested but unexercised portion of the Option (and any other stock options granted under the Plan), which shall be exercisable in accordance with the terms thereof, and (b) accrued but unpaid allowances and expense reimbursements and
applicable death benefits, if any. If you become unable to perform your duties because of a “disability” we may terminate your employment. In this event, we will pay your unpaid Base Salary, accrued but unpaid allowances, expense
reimbursements, and incentive compensation from the date of your first absence from work due to your disability through the third month following the date of termination, less disability benefits received through our benefit plan. Your option shall
terminate except for any vested but unexercised portion thereof (and any other stock options granted under the Plan). “Disability” means an incapacity due to physical or mental illness, that causes you to be absent from your duties on a
full-time basis for three consecutive months, or for an aggregate of six months in any consecutive 12-month period, and a physician selected by us concludes that (A) you are suffering from “total disability” as defined in the our
disability insurance policy and (B) within 30 days after written notice thereof is given by the Company to you, you have not returned to work on a full time basis. 

  

	 	11.	Agreement not to Disclose Trade Secrets or Confidential Information. Upon the effective date of this Agreement and for two years after its termination, you shall not disclose
or utilize any trade secrets, confidential information, or other proprietary information acquired by you during the course and solely as a 

 result of your service with EDI. As used herein, “trade secret” means the whole or any portion
or phase of any formula, pattern, device, combination of devices, source-code of any proprietary software, or compilation of any scientific, technical or commercial information, including any design, list of suppliers, list of customers or
improvement thereof, as well as pricing information or methodology, contractual arrangements with vendors or suppliers, business development plans or activities, or financial information of EDI that is for use, or is used, in the operation of
EDI’s businesses that is not commonly known by or available to the public and that derives economic value from not being generally known to, and not being readily ascertainable by proper means by, other persons who can obtain economic value
from its disclosure or use and is the subject of efforts that are reasonable under the circumstances to maintain its secrecy. You agree to return to EDI any and all such trade secrets, confidential information or other proprietary information
immediately upon the termination of this Agreement. 
  

	 	12.	Covenant not to Compete. Provided this Agreement is not terminated by EDI without “cause” or by you for “good reason” or upon a “change of
control,” you shall not, after the effective date of this agreement and for twelve (12) months after its termination, (A) enter into any employment, consulting or other similar business relationship with a provider of online fitness or
nutrition programs where your duties or responsibilities are the same, or substantially the same, as your duties and responsibilities with EDI, or (B) acquire a 20% or greater ownership interest in or enter into any other similar arrangement, with
any company, partnership, joint venture or other business organization that provides online fitness or nutrition programs as of the time of such termination in any geographic area in which EDI conducts business as of the time of such termination.
You acknowledge and agree that the remedy at law for any breach, or threatened breach, of any of the provisions of this Paragraph 12 will be inadequate and, accordingly, you covenant and agree that EDI shall, in addition to any other rights or
remedies that EDI may have, be entitled to such equitable and injunctive relief as may be available from any court of competent jurisdiction to restrain you from any violation of this Paragraph. Such right to obtain injunctive relief may be
exercised, at the option of EDI, in addition to, concurrently with, prior to, after, or in lieu of, the exercise of any other rights or remedies that EDI may have as a result of any such breach or threatened breach. 

  

	 	13.	Indemnification. You shall be entitled to indemnification from EDI to the fullest extent permitted under the EDI’s then-current Articles of Incorporation and Bylaws and
under the law of the state of Delaware. We shall use our reasonable best efforts to obtain coverage for you under any insurance policy obtained during the term of this Agreement that covers the officers and directors of EDI against liability in
connection with their service to EDI. 

  

	 	14.	Governing Law. This Agreement and the rights and obligations hereunder shall be governed by the laws of the State of Florida and the parties to this Agreement specifically
consent to the jurisdiction of the courts of the State of Florida over any action arising out of or related to this Agreement. 

  

	
	Very Truly Yours,
	
	 /s/ Ciaran G. McCourt

	 Ciaran G. McCourt,

	 President and Chief Operating Officer

  

			
	 Agreed:
	 	 
		
	 BY:
	 	 /s/ Robert T. Hamilton

	 PRINT NAME:
	 	 Robert T. Hamilton

	 DATE:
	 	 April 26, 2005

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}]]